Returning guest, Dr. Jeffrey Dlott, Medical Director at Quest Direct discusses the new “Future of Personalized Healthcare Insights Study 2022” that was conducted by Leaf Group in collaboration with Quest Direct and Well+Good. The study provides a deeper understanding of perceptions and preferences around telehealth, health data usage, and tech adoption, as well as ways to improve a patient’s healthcare journey.
Dr. Jeffrey Dlott currently serves as Medical Director of Quest’s consumer health offering, QuestDirect. Dr. Dlott is a clinical pathologist who joined Quest Diagnostics in 2005 as Medical Director of Coagulation and Immunohematology. He received his medical degree at the University of Texas Health Science Center in San Antonio.